Comment

. 2021 May;60(5):677-679.

doi: 10.1007/s40262-021-00993-4. Epub 2021 Mar 13.

Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II"

Swantje Völler¹, Robert B Flint^{2

3}, Sinno H P Simons², Catherijne A J Knibbe^{4

5}

Affiliations

¹ Leiden Academic Centre for Drug Research, Pharmacy, Leiden University, Leiden, The Netherlands. s.voller@lacdr.leidenuniv.nl.
² Division of Neonatology, Department of Pediatrics, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
³ Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
⁴ Leiden Academic Centre for Drug Research, Systems Biomedicine and Pharmacology, Leiden University, Leiden, The Netherlands.
⁵ Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.

PMID: 33713305
PMCID: PMC8113170
DOI: 10.1007/s40262-021-00993-4

Comment

Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II"

Swantje Völler et al. Clin Pharmacokinet. 2021 May.

. 2021 May;60(5):677-679.

doi: 10.1007/s40262-021-00993-4. Epub 2021 Mar 13.

Authors

Swantje Völler¹, Robert B Flint^{2

3}, Sinno H P Simons², Catherijne A J Knibbe^{4

5}

Affiliations

¹ Leiden Academic Centre for Drug Research, Pharmacy, Leiden University, Leiden, The Netherlands. s.voller@lacdr.leidenuniv.nl.
² Division of Neonatology, Department of Pediatrics, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
³ Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
⁴ Leiden Academic Centre for Drug Research, Systems Biomedicine and Pharmacology, Leiden University, Leiden, The Netherlands.
⁵ Department of Clinical Pharmacy, St Antonius Hospital, Nieuwegein, The Netherlands.

PMID: 33713305
PMCID: PMC8113170
DOI: 10.1007/s40262-021-00993-4

Erratum in

Correction to: Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II".
Völler S, Flint RB, Simons SHP, Knibbe CAJ. Völler S, et al. Clin Pharmacokinet. 2022 May;61(5):759. doi: 10.1007/s40262-022-01117-2. Clin Pharmacokinet. 2022. PMID: 35301708 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Comment in

Authors' Reply to Völler et al: "Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II".
Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Abduljalil K, et al. Clin Pharmacokinet. 2021 May;60(5):681-683. doi: 10.1007/s40262-021-00995-2. Epub 2021 Mar 13. Clin Pharmacokinet. 2021. PMID: 33713304 No abstract available.

Comment on

A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building.
Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Abduljalil K, et al. Clin Pharmacokinet. 2020 Apr;59(4):485-500. doi: 10.1007/s40262-019-00825-6. Clin Pharmacokinet. 2020. PMID: 31583613
Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Abduljalil K, et al. Clin Pharmacokinet. 2020 Apr;59(4):501-518. doi: 10.1007/s40262-019-00827-4. Clin Pharmacokinet. 2020. PMID: 31587145 Clinical Trial.

Cited by

Authors' Reply to Völler et al: "Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II".
Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Abduljalil K, et al. Clin Pharmacokinet. 2021 May;60(5):681-683. doi: 10.1007/s40262-021-00995-2. Epub 2021 Mar 13. Clin Pharmacokinet. 2021. PMID: 33713304 No abstract available.

References

1. Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population. Clin Pharmacokinet. 2020;59(4):501–518. doi: 10.1007/s40262-019-00827-4. - DOI - PubMed
1. Abduljalil K, Pan X, Pansari A, Jamei M, Johnson TN. A Preterm physiologically based pharmacokinetic model. Part I: physiological parameters and model building. Clin Pharmacokinet. 2020;59(4):485–500. doi: 10.1007/s40262-019-00825-6. - DOI - PubMed
1. Allegaert K, Van Den Anker JN. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol. 2015;80(4):788–795. doi: 10.1111/bcp.12430. - DOI - PMC - PubMed
1. Bartelink IH, Rademaker CMA, Schobben AFAM, Van Den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet. 2006;45(11):1077–1097. doi: 10.2165/00003088-200645110-00003. - DOI - PubMed
1. Vrancken SL, van Heijst AF, de Boode WP. Neonatal hemodynamics: from developmental physiology to comprehensive monitoring. Front Pediatr. 2018;6:87. doi: 10.3389/fped.2018.00087. - DOI - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II"

Affiliations

Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II"

Authors

Affiliations

Erratum in

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources